7 Results

People

  1. Rotolo
    Rotolo
  2. Van Den Brink
    Van Den Brink
  3. Alpdogan
    Alpdogan
  4. Willis
    Willis
  5. Kappel
    Kappel
  6. Muriglan
    Muriglan
  7. Schmaltz
    Schmaltz
  8. Greenberg
    Greenberg
  9. Eng
    Eng
  10. King
    King

Groups

  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. Executive Committee, Center for Hematologic Malignancies (7)
  4. GSK Faculty (7)
  5. Hematologic Malignancies, Division of (7)
  6. Immunology Program Faculty (7)
  7. Sloan Kettering Institute Faculty (7)
  8. Division of Subspecialty Medicine (2)
  9. Endocrinology (2)
  10. Molecular Pharmacology and Chemistry Program Faculty (2)
  1. "nonhuman"
  2. "Center for Hematologic Malignancies"
  3. "Hematologic Malignancies, Division of"
  4. "GSK Faculty"
  5. "Jimmy Rotolo"
Formats
  1. Journal Article (7)
Groups
  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. Executive Committee, Center for Hematologic Malignancies (7)
  4. GSK Faculty (7)
  5. Hematologic Malignancies, Division of (7)
  6. Immunology Program Faculty (7)

More Groups

People
  1. Jimmy Rotolo (7)
  2. Marcel Van Den Brink (7)
  3. Lucy Willis (5)
  4. Seyfettin Alpdogan (5)
  5. Barry Kappel (4)
  6. Cornelius Schmaltz (4)

More People

Years
  1. 2011 (1)
  2. 2010 (1)
  3. 2009 (1)
  4. 2003 (2)
  5. 2002 (1)
  6. 2001 (1)
Publications
  1. Blood (4)
  2. Nature Medicine (1)
  3. PLoS ONE (1)
  4. Transplantation (1)
Publishers
  1. American Society of Hematology (4)
  2. Lippincott Williams & Wilkins (1)
  3. Nature Publishing Group (1)
  4. Public Library of Science (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation
    Journal Article

    Lu, S. X.; Kappel, L. W.; Charbonneau Allard, A. M.; Atallah, R.; Holland, A. M.; Turbide, C.; Hubbard, V. M.; Rotolo, J. A.; Smith, M.; Suh, D.; more...
    PLoS ONE (2011)

    Fulltext@MSK | Save
  • Response: Sample size and statistical comparisons of GVHD rates in pediatric Niemann-Pick disease patients
    Journal Article

    Kolesnick, R.; Van Den Brink, M.; Heller, G.; Rotolo, J. A.
    Blood (2010)

    Fulltext@MSK | Save
  • Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease
    Journal Article

    Rotolo, J. A.; Stancevic, B.; Lu, S. X.; Zhang, J.; Suh, D.; King, C. G.; Kappel, L. W.; Murphy, G. F.; Liu, C.; Fuks, Z.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation
    Journal Article

    Schmaltz, C.; Alpdogan, O.; Muriglan, S. J.; Kappel, B. J.; Rotolo, J. A.; Ricchetti, E. T.; Greenberg, A. S.; Willis, L. M.; Murphy, G. F.; Crawford, J. M.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation
    Journal Article

    Alpdogan, O.; Muriglan, S. J.; Kappel, B. J.; Doubrovina, E.; Schmaltz, C.; Schiro, R.; Eng, J. M.; Greenberg, A. S.; Willis, L. M.; Rotolo, J. A.; more...
    Transplantation (2003)

    Fulltext@MSK | Save
  • T cells require TRAIL for optimal graft-versus-tumor activity
    Journal Article

    Schmaltz, C.; Alpdogan, O.; Kappel, B. J.; Muriglan, S. J.; Rotolo, J. A.; Ongchin, J.; Willis, L. M.; Greenberg, A. S.; Eng, J. M.; Crawford, J. M.; more...
    Nature Medicine (2002)

    Fulltext@MSK | Save
  • Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease
    Journal Article

    Alpdogan, O.; Schmaltz, C.; Muriglan, S. J.; Kappel, B. J.; Perales, M. A.; Rotolo, J. A.; Halm, J. A.; Rich, B. E.; van den Brink, M. R. M.
    Blood (2001)

    Fulltext@MSK | Save